SGYP

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approval announced January 25, 2018.
Trulance (plecanatide)
Constipation-predominant irritable bowel syndrome (IBS-C)
Approved January 19, 2017.
Trulance (plecanatide)
Chronic idiopathic constipation (CIC)

Latest News

  1. FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC - UXIN, SGYP & MHLD
  2. SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Synergy Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  3. FRIDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Synergy Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  4. SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP
  5. DEADLINE FRIDAY REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Synergy Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  6. SGYP & MHLD - Class Action Bronstein, Gewirtz & Grossman, LLC
  7. DEADLINE FRIDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Synergy Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  8. SYNERGY INVESTORS APRIL 12th DEADLINE ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc.; Encourages Investors With Losses In Excess of $100K to Contact the Firm – SGYP
  9. Class Action Bronstein, Gewirtz & Grossman, LLC - SGYP & MHLD
  10. Class Action Reminder Bronstein, Gewirtz & Grossman, LLC - SGYP & MHLD
  11. Bronstein, Gewirtz & Grossman, LLC Class Action Update - UXIN, SGYP & MHLD
  12. Bronstein, Gewirtz & Grossman, LLC Class Action Reminder - UXIN, SGYP & MHLD